Davidson Matt bought ADIL
October 28, 2026 · Form 4 insider transaction
Davidson Matt bought 31,914 shares of Adial Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
31,914
Price
N/A
Total value
N/A
InsiderDavidson Matt
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 28, 2026
Filing dateOctober 30, 2026
Shares owned after31,914
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Received in exchange for a stock option to acquire 100,000 shares of Old Azora common stock with an exercise price of $0.50 per share pursuant to the Merger Agreement, which grant was subject to stockholder approval of the Preferred Stock Conversion Proposal. The Issuer's stockholders approved the Preferred Stock Conversion Proposal on the Conversion Proposal Approval Date.; Immediately exercisable.